SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-22-002767
Filing Date
2022-11-14
Accepted
2022-11-14 17:22:01
Documents
6
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q axim_10q.htm 10-Q 1253993
2 CERTIFICATION axim_ex311.htm EX-31.1 13600
3 CERTIFICATION axim_ex312.htm EX-31.2 13332
4 CERTIFICATION axim_ex321.htm EX-32.1 4210
5 CERTIFICATION axim_ex322.htm EX-32.2 4272
6 axim_10qimg1.jpg GRAPHIC 4951
  Complete submission text file 0001096906-22-002767.txt   1297489
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54296 | Film No.: 221387861
SIC: 2834 Pharmaceutical Preparations